InvestorsHub Logo
Followers 8
Posts 1427
Boards Moderated 0
Alias Born 06/30/2016

Re: fabius post# 35467

Thursday, 06/28/2018 12:14:41 PM

Thursday, June 28, 2018 12:14:41 PM

Post# of 38634
Fabius, That was my point. I think even as shareholders we need to analyze what went wrong with PTIE. I can not believe they submitted studies that showed it did not work. If the studies were not good, I would hold off and not waste the application and time.

Then again, is this why Purdue did not file suit against them when they did file? did they know their product was inferior and therefore not a threat?

I still have memories of our own adcomm and where panelists pointed out that Rexista could still be injectable and totally bypassed the fact it was still better than Purdues. even to the one germane question of did IPCI prove it was IV resistant the panel said NO !

lets hope they partner Rexsita before going to the next adcom and have some top notch people there. someone who can think like a lawyer and on their feet and respond to issues as they come up.

But this is just a thought pattern I have at the moment. If no one knows for sure, I guess I will be doing some investigation into the matter and see what I come up with. But I just was a little taken back that it was such an overwhelming denial. Knowing they did submit all their tests. who would submit inferior test results?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y